CODEX+ CELIDA Recommendations
1.5.2 - ci-build

CODEX+ CELIDA Recommendations - Local Development build (v1.5.2) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

PlanDefinition: Therapeutic Anticoagulation Plan (hospitalised, non-intensive care, COVID-19 patients with no renal function impairment (eGFR >= 30ml/min)) (Experimental)

Official URL: https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/intervention-plan/therapeutic-anticoagulation Version: 7.0
Active as of 2022-02 Responsible: NUM CODEX+ CELIDA Computable Name: Therapeutic_Anticoagulation_No_Renal_Function_Impairment

In hospitalized, non-intensive care patients with COVID-19 and increased risk (e.g., D-dimers ≥ 2 mg/l), therapeutic anticoagulation can be considered if the risk of bleeding is low. Anticoagulation, preferentially with NMH or UFH, can be considered.

Generated Narrative: PlanDefinition TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan

url: PlanDefinition Therapeutic Anticoagulation Plan (hospitalised, non-intensive care, COVID-19 patients

version: 7.0

name: Therapeutic_Anticoagulation_No_Renal_Function_Impairment

title: Therapeutic Anticoagulation Plan (hospitalised, non-intensive care, COVID-19 patients

type: ECA Rule

status: Active

experimental: true

subject: Population: Hospitalised COVID-19 patients without the need for intensive care therapy considered high-risk for developing venous thrombosis

date: 2022-02

publisher: NUM CODEX+ CELIDA

description:

In hospitalized, non-intensive care patients with COVID-19 and increased risk (e.g., D-dimers ≥ 2 mg/l), therapeutic anticoagulation can be considered if the risk of bleeding is low. Anticoagulation, preferentially with NMH or UFH, can be considered.

goal

id

aPTT-goal

category: Lab findings surveillance (regime/therapy)

description: aPTT value should be > 50 sec.

Targets

-MeasureDetail[x]
*aPTT in Blood by Coagulation assay50.0000001-? sec

action

code: Administration of substance (procedure)

goalId: aPTT-goal

definition: Therapeutic Anticoagulation Treatment UFH

action

code: Administration of substance (procedure)

definition: Therapeutic Anticoagulation Treatment with Dalteparin

action

code: Administration of substance (procedure)

definition: Therapeutic Anticoagulation Treatment with Dalteparin

action

code: Administration of substance (procedure)

definition: Therapeutic Anticoagulation Treatment with Dalteparin

action

code: Administration of substance (procedure)

definition: Therapeutic Anticoagulation Treatment with Nadroparin

action

code: Administration of substance (procedure)

definition: Therapeutic Anticoagulation Treatment with Enoxaparin

action

code: Administration of substance (procedure)

definition: Therapeutic Anticoagulation Treatment with Enoxaparin

action

code: Administration of substance (procedure)

definition: Therapeutic Anticoagulation Treatment with Certoparin

action

code: Administration of substance (procedure)

definition: Therapeutic Anticoagulation Treatment with Fondaparinux

action

code: Administration of substance (procedure)

goalId: aPTT-goal

definition: Therapeutic Anticoagulation Treatment with Argatroban

action

code: Administration of substance (procedure)

definition: Therapeutic Anticoagulation Treatment with Tinzaparin